MedRx Co., Ltd (TYO:4586)
Japan · Delayed Price · Currency is JPY 85.00
-1.00 (-1.16%)
Apr 21, 2026, 3:30 PM JST
MedRx Market Cap
MedRx has a market cap or net worth of 5.05 billion as of April 21, 2026. Its market cap has increased by 26.48% in one year.
Market Cap
5.05B
Enterprise Value
3.29B
Revenue
128.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
85.00
Market Cap Chart
Since February 13, 2013, MedRx's market cap has decreased from 11.76B to 5.05B, a decrease of -57.10%. That is a compound annual growth rate of -6.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 5.05B | -21.30% |
| Dec 30, 2025 | 6.41B | 65.15% |
| Dec 30, 2024 | 3.88B | -32.98% |
| Dec 29, 2023 | 5.79B | 117.37% |
| Dec 30, 2022 | 2.67B | -15.34% |
| Dec 30, 2021 | 3.15B | -20.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 19.46B |
| Pharma Foods International | 19.40B |
| Taiko Pharmaceutical | 15.03B |
| Wakamoto Pharmaceutical | 12.28B |
| Solasia Pharma K.K. | 11.19B |
| Morishita Jintan | 9.15B |
| Cyfuse Biomedical K.K. | 7.22B |
| SymBio Pharmaceuticals | 6.96B |